Matricellular proteins in cardiac adaptation and disease

Research output: Contribution to journalArticle

233 Citations (Scopus)

Abstract

The term matricellular proteins describes a family of structurally unrelated extracellular macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue architecture, but are induced following injury and modulate cell-cell and cell-matrix interactions. When released to the matrix, matricellular proteins associate with growth factors, cytokines, and other bioactive effectors and bind to cell surface receptors transducing signaling cascades. Matricellular proteins are upregulated in the injured and remodeling heart and play an important role in regulation of inflammatory, reparative, fibrotic and angiogenic pathways. Thrombospondin (TSP)-1, -2, and -4 as well as tenascin-C and -X secreted protein acidic and rich in cysteine (SPARC), osteopontin, periostin, and members of the CCN family (including CCN1 and CCN2/connective tissue growth factor) are involved in a variety of cardiac pathophysiological conditions, including myocardial infarction, cardiac hypertrophy and fibrosis, aging-associated myocardial remodeling, myocarditis, diabetic cardiomyopathy, and valvular disease. This review discusses the properties and characteristics of the matricellular proteins and presents our current knowledge on their role in cardiac adaptation and disease. Understanding the role of matricellular proteins in myocardial pathophysiology and identification of the functional domains responsible for their actions may lead to design of peptides with therapeutic potential for patients with heart disease.

Original languageEnglish (US)
Pages (from-to)635-688
Number of pages54
JournalPhysiological Reviews
Volume92
Issue number2
DOIs
StatePublished - Apr 1 2012

Fingerprint

Heart Diseases
Proteins
Diabetic Cardiomyopathies
Thrombospondin 1
Connective Tissue Growth Factor
Tenascin
Osteopontin
Myocarditis
Cardiomegaly
Cell Surface Receptors
Cell Communication
Cysteine
Intercellular Signaling Peptides and Proteins
Fibrosis
Myocardial Infarction
Cytokines
Peptides
Wounds and Injuries

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Physiology (medical)

Cite this

Matricellular proteins in cardiac adaptation and disease. / Frangogiannis, Nikolaos G.

In: Physiological Reviews, Vol. 92, No. 2, 01.04.2012, p. 635-688.

Research output: Contribution to journalArticle

@article{2fa4c6d9826c4a6da8f3e96a2ddc49ab,
title = "Matricellular proteins in cardiac adaptation and disease",
abstract = "The term matricellular proteins describes a family of structurally unrelated extracellular macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue architecture, but are induced following injury and modulate cell-cell and cell-matrix interactions. When released to the matrix, matricellular proteins associate with growth factors, cytokines, and other bioactive effectors and bind to cell surface receptors transducing signaling cascades. Matricellular proteins are upregulated in the injured and remodeling heart and play an important role in regulation of inflammatory, reparative, fibrotic and angiogenic pathways. Thrombospondin (TSP)-1, -2, and -4 as well as tenascin-C and -X secreted protein acidic and rich in cysteine (SPARC), osteopontin, periostin, and members of the CCN family (including CCN1 and CCN2/connective tissue growth factor) are involved in a variety of cardiac pathophysiological conditions, including myocardial infarction, cardiac hypertrophy and fibrosis, aging-associated myocardial remodeling, myocarditis, diabetic cardiomyopathy, and valvular disease. This review discusses the properties and characteristics of the matricellular proteins and presents our current knowledge on their role in cardiac adaptation and disease. Understanding the role of matricellular proteins in myocardial pathophysiology and identification of the functional domains responsible for their actions may lead to design of peptides with therapeutic potential for patients with heart disease.",
author = "Frangogiannis, {Nikolaos G.}",
year = "2012",
month = "4",
day = "1",
doi = "10.1152/physrev.00008.2011",
language = "English (US)",
volume = "92",
pages = "635--688",
journal = "Physiological Reviews",
issn = "0031-9333",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Matricellular proteins in cardiac adaptation and disease

AU - Frangogiannis, Nikolaos G.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - The term matricellular proteins describes a family of structurally unrelated extracellular macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue architecture, but are induced following injury and modulate cell-cell and cell-matrix interactions. When released to the matrix, matricellular proteins associate with growth factors, cytokines, and other bioactive effectors and bind to cell surface receptors transducing signaling cascades. Matricellular proteins are upregulated in the injured and remodeling heart and play an important role in regulation of inflammatory, reparative, fibrotic and angiogenic pathways. Thrombospondin (TSP)-1, -2, and -4 as well as tenascin-C and -X secreted protein acidic and rich in cysteine (SPARC), osteopontin, periostin, and members of the CCN family (including CCN1 and CCN2/connective tissue growth factor) are involved in a variety of cardiac pathophysiological conditions, including myocardial infarction, cardiac hypertrophy and fibrosis, aging-associated myocardial remodeling, myocarditis, diabetic cardiomyopathy, and valvular disease. This review discusses the properties and characteristics of the matricellular proteins and presents our current knowledge on their role in cardiac adaptation and disease. Understanding the role of matricellular proteins in myocardial pathophysiology and identification of the functional domains responsible for their actions may lead to design of peptides with therapeutic potential for patients with heart disease.

AB - The term matricellular proteins describes a family of structurally unrelated extracellular macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue architecture, but are induced following injury and modulate cell-cell and cell-matrix interactions. When released to the matrix, matricellular proteins associate with growth factors, cytokines, and other bioactive effectors and bind to cell surface receptors transducing signaling cascades. Matricellular proteins are upregulated in the injured and remodeling heart and play an important role in regulation of inflammatory, reparative, fibrotic and angiogenic pathways. Thrombospondin (TSP)-1, -2, and -4 as well as tenascin-C and -X secreted protein acidic and rich in cysteine (SPARC), osteopontin, periostin, and members of the CCN family (including CCN1 and CCN2/connective tissue growth factor) are involved in a variety of cardiac pathophysiological conditions, including myocardial infarction, cardiac hypertrophy and fibrosis, aging-associated myocardial remodeling, myocarditis, diabetic cardiomyopathy, and valvular disease. This review discusses the properties and characteristics of the matricellular proteins and presents our current knowledge on their role in cardiac adaptation and disease. Understanding the role of matricellular proteins in myocardial pathophysiology and identification of the functional domains responsible for their actions may lead to design of peptides with therapeutic potential for patients with heart disease.

UR - http://www.scopus.com/inward/record.url?scp=84860145209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860145209&partnerID=8YFLogxK

U2 - 10.1152/physrev.00008.2011

DO - 10.1152/physrev.00008.2011

M3 - Article

C2 - 22535894

AN - SCOPUS:84860145209

VL - 92

SP - 635

EP - 688

JO - Physiological Reviews

JF - Physiological Reviews

SN - 0031-9333

IS - 2

ER -